-->
  SpraySpheres™, Sproapl™, Sprayspheres™

Partnering:-

Pioma Chemicals & Umang Pharmatech have experience and knowledge of speciality polymers & excipients since more than two decades to offer to the Global Pharmaceutical Market.

Our venture with Umang Pharmatech will help customers to get consistant and high quality excipients under one roof with complete techno commercial support that is much more above the customer expectation. We sincerely thanks entire team of Umang Pharmatech for developing quality & cost effective World Class Excipients that meets the Global Standards for regulatory market & allow us to market these ingredients in World market.

Today every pharma scientists are looking for easy, innovative, safe & cost effective ingredients for their novel drug delivery formulations. We are presenting innovative speciality excipients & polymers exclusively for your every solid dosage drug delivery formulations in pharmaceutical segment.

• Sprayspheres™ SS (Sugar Sphere)
• Spraypol™ (Methacrylic Copolymer)
• Sprayspheres™ MCC (MCC Sphere)

Partnering with customers:-
Our technical & commercial network will give you support at every stage of your formulation development via enhanced formulation technologies to unique customer products with individually design release profiles without compromising in quality at cost effective way.

What is Sprayspheres MCC ?
They are nothing but Spherical Size of Microcrystalline Cellulose Granules
   
Why MCC Sphers?
MCC is a purifield, partly depolymerised celuious, prepared from high quality of cellulose.
   
High Controlled-Release Performance
Very easy to use in formulations that reduce time consuming effort for processing time
  a) Time consuming effort for processing time
  b) Directly compressible products
   
Applications
Used as cores to be coated in Pharmaceutical
Accurate & consistent for drug layering and Coating
Suitable for Non-Cariogenic products
It gives good drug dissolution profile due to its accurate & consistent particle size.
It helps in producing narrow size of Sustained Released or Controlled Released Granules.
 
  What is Sprayspheres SS ?
 
It is fine and Spherical Size of Granules containing not more than 92% Sucrose
   
Why Sugar Sphers?
High Controlled-Release Performance.
Sugarsphere are inert pallets composed by sucrose & maize starch
Very accurate for drug loading
Gives uniformity of drug content in final dosage (Caspule)
   
Application
Sugarspheres are drug free cores
Very accurate for drug loading
Gives uniformity of drug content in final dosage (Capsules)
It gives good drug dissolution profile due to its accurate & consistent particle size.
   
 

Our Supports

Production facility meets with cGMP Standards.
Products are complies with all the Global Pharmacopiel Standards including USP/EP/BP/JP
Products are produced from high quality of ingredients
Technical & documentry support available for regulatory market
 
Every formulation is different and it needs specific sizes
of Spherical Excipients according to drug loading in the formulations.

We thanks to our venture Umang Pharmatech as to produce
narrow size of MCC Spheres that meets Global Pharma World.
 Sugar is one of very critical ingredient in sustained release - drug delivery in pharmaceutical formulations.

We sincerly thanks our venture company Umang Pharmatech as to provide consistent and world class quality of Sugarspheres that meets every formulation needs.

Particle Size
Average particle size 75-150 µm
Average particle size 150-225 µm
Average particle size 225-300 µm
Average particle size 300-375 µm
Average particle size 375-450 µm
Average particle size 450-525 µm
Average particle size 525-600 µm
Average particle size 600-675 µm
Average particle size 675-750 µm
Average particle size 750-825 µm
Average particle size 825-900 µm
Average particle size 900-1000 µm

Particle Size
Mesh size (ASTM) 120-140
Mesh size (ASTM) 100-120
Mesh size (ASTM) 80-100
Mesh size (ASTM) 70-80
Mesh size (ASTM) 50-70
Mesh size (ASTM) 45-50
Mesh size (ASTM) 40-45
Mesh size (ASTM) 35-40
Mesh size (ASTM) 30-35
Mesh size (ASTM) 25-30
Mesh size (ASTM) 20-25
Mesh size (ASTM) 18-20
 
*Specific size are made available on special request.
 
 
Spraypol™ (Methacrylic Copolymer )

 
Type   Application   Dissolutions Properties   Functionality   Grades   Nature & Polymer Content   Advantages
ENTERIC COATING

SPRAYPOL™ L

  

Drug delivery in duodenum duodenum





Drug delivery in jejunum 		 

Soluble in intestinal fluid above pH 5.5




Soluble in intestinal fluid above pH 6.0		  

anicnic polymers of methascylic acid and ethacrylates with - COOH functional groups


anicnic polymers of methascylic acid and ethacrylates with - COOH functional groups

 

SPRAYPOL™ L100-55 S

PRAYPOL™ L30D-55


SPRAYPOL™ L100		  

Power 95%


aqueous
dispersion 30%

Power 95%
 

Effective and Safe enteric coating



Site specific drug delivery
above pH 6.0 in intestine by combination
with SPRAYPOL S/L grades
SPRAYPOL™ S
    Drug delivery in ileum   Soluble in intestinal fluid above pH 7.0   anicnic polymers of methascylic acid and ethacrylates with - COOH functional groups   SPRAYPOL™ S100   Power 95%   Site specific drug delivery in intestine by combination with SPRAYPOL S/L grades
TASTEM ODOUR MASKING, MOISTURE PROTECTION & IMMEDIATE RELEASE COATING
SPRAYPOL™ E                        
    Taste and odour masking, insulating coating, transdermal moisture protection applications   Soluble in gastric fluid up to pH 5   Cationic polymer with a dimethylamine ammonium   SPRAYPOL™ E100   Granules 98%   No plasticizer necessary
    Moisture protection, Taste and odour masking   Swellable and permeable above pH 5.0   functional groups   SPRAYPOL™ E PO   Power 98%   aqueous formulations
 

SPRAYPOL™ Quality & Features

pH-dependent drug release
Protection of actives sensitive to gastric fluid
Protection of gastric mucosa from aggressive actives
Increase in drug effectiveness
Good storage stability
GI and colon targeting

 

Spraypol™ (Methacrylic Copolymer )

Spraypol - Advantage for Enteric Coatings:

pH-dependent drug release
Protection of actives sensitives to gastric fluid
Protection of gastric mucosa from aggressive actives
Increase in drug effectiveness
Good Storage Stability
GI nd colon targeting
 

Advantages for Sustained drug release Coatings:

Time-controlled release of active ingredient
Therapeutically customized release profiles
Higher patient compliance due to reduced number of doses to be taken
Cost-effective processing
 
 
Advantages for Protective Coatings:
   
pH-dependent drug release
Protection of sensitive actives
Taste and odor masking
Moisture protection
Good storage stability
Improved passage of the dosage form
Smooth and glossy surfaces, good colorcoating